Overview

Update
IPO / Stock
Went Public on Jan 27, 2016 / NASDAQ:EXDX
Total Equity Funding
$99.04M in 11 Rounds from 7 Investors
Headquarters:
Albuquerque, NM
Description:
Exagen Diagnostics is a patient-focused, discovery-driven molecular diagnostics laboratory with internally-developed genomic tests.
Founders:
,
Categories:
Biotechnology, Health Diagnostics, Medical
Website:
http://avisetest.com
Social:

Company Details

Update

Exagen Diagnostics is a patient focused, discovery driven CLIA registered molecular diagnostics laboratory with a growing menu of proprietary, internally developed genomic tests. Exagen is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management.

Funding Rounds (20) - $157.75M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2016$2.1M / Post Ipo Debt0
Jan, 2016$16.8M / Post Ipo Equity0
Jul, 2015$3M / Post Ipo Debt0
Apr, 2015$1.82M / Post Ipo Debt0
Jul, 2014$3.95M / Debt Financing4
Nov, 2013$25M / Debt Financing6
Oct, 2013$5.02M / Series C0
Nov, 2012$123.75k / Debt Financing0
Sep, 2012$5.3M / Private Equity5
Feb, 2012$34.1M / Series C3
Dec, 2011$11.99M / Private Equity3
Nov, 2011$1M / Debt Financing0
Sep, 2011$4.91M / Debt Financing0
Jun, 2011$4.91M / Private Equity0
May, 2011$5.43M / Private Equity5
Feb, 2011$16.9M / Series B5
Oct, 2010$2M / Private Equity0
May, 2009$1M / Venture0
Jun, 2005$7M / Series B3
Jan, 2004$5.4M / Series A3

Current Team (3)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    Science & Technology Park

    801 University Blvd. SE, Suite 103

    Albuquerque, NM 87106

    USA

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos